Search Results - "Maciag, Lidia"

Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms by Arcila, Maria E., Yu, Wayne, Syed, Mustafa, Kim, Hannah, Maciag, Lidia, Yao, JinJuan, Ho, Caleb, Petrova, Kseniya, Moung, Christine, Salazar, Paulo, Rijo, Ivelise, Baldi, Tessara, Zehir, Ahmet, Landgren, Ola, Park, Jae, Roshal, Mikhail, Dogan, Ahmet, Nafa, Khedoudja

“…Immunoglobulin heavy chain (IGH) clonality testing by next-generation sequencing (NGS) offers unique advantages over current low-throughput methods in the…”
Get full text

Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms by Liu, Ying, Ho, Caleb, Yu, Wayne, Huang, Ying, Miller, Jeffrey, Gao, Qi, Syed, Mustafa, Ma, Yuanyuan, Wang, Meiyi, Maciag, Lidia, Petrova-Drus, Kseniya, Zhu, Menglei, Yao, JinJuan, Vanderbilt, Chad, Durham, Benjamin, Benhamida, Jamal, Ewalt, Mark D, Dogan, Ahmet, Roshal, Mikhail, Nafa, Khedoudja, Arcila, Maria E

“…Next-generation sequencing (NGS)-based measurable residual disease (MRD) monitoring in post-treatment settings can be crucial for relapse risk stratification…”
Get full text

Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma by Petrova-Drus, Kseniya, Syed, Mustafa, Yu, Wayne, Hutt, Kasey, Zlotnicki, Alyssa M., Huang, Ying, Kamalska-Cyganik, Monika, Maciag, Lidia, Wang, Meiyi, Ma, Yuanyuan G., Ho, Caleb, Moung, Christine, Yao, Jinjuan, Nafa, Khedoudja, Baik, Jeeyeon, Vanderbilt, Chad M., Benhamida, Jamal K., Liu, Ying, Zhu, Menglei, Durham, Benjamin, Ewalt, Mark D., Salazar, Paulo, Rijo, Ivelise, Baldi, Tessara, Mato, Anthony, Roeker, Lindsey E., Roshal, Mikhail, Dogan, Ahmet, Arcila, Maria E.

“…Somatic hypermutation status of the IGHV gene is essential for treating patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Unlike the…”
Get full text

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry by Ho, Caleb, Syed, Mustafa, Roshal, Mikhail, Petrova-Drus, Kseniya, Moung, Christine, Yao, Jinjuan, Quesada, Andres E, Benhamida, Jamal, Vanderbilt, Chad, Liu, Ying, Zhu, Menglei, Yu, Wayne, Maciag, Lidia, Wang, Meiyi, Ma, Yuanyuan, Gao, Qi, Rustad, Even H, Hultcrantz, Malin, Diamond, Benjamin T, Zheng-Lin, Binbin, Huang, Ying, Hutt, Kasey, Miller, Jeffrey E, Dogan, Ahmet, Nafa, Khedoudja, Landgren, Ola, Arcila, Maria E

“…The 2016 International Myeloma Working Group consensus recommendations emphasize high-sensitivity methods for minimal residual disease (MRD) detection,…”
Get full text

Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform Comparison by Petrova-Drus, Kseniya, Syed, Mustafa, Yu, Wayne, Hutt, Kasey, Zlotnicki, Alyssa M, Huang, Ying, Kamalska-Cyganik, Monika, Maciag, Lidia, Wang, Meiyi, Ma, Yuanyuan G, Ho, Caleb, Moung, Christine, Yao, Jinjuan, Nafa, Khedoudja, Baik, Jeeyeon, Vanderbilt, Chad M, Benhamida, Jamal K, Liu, Ying, Zhu, Menglei, Durham, Benjamin, Ewalt, Mark D, Salazar, Paulo, Rijo, Ivelise, Baldi, Tessara, Mato, Anthony, Roeker, Lindsey E, Roshal, Mikhail, Dogan, Ahmet, Arcila, Maria E

“…Somatic hypermutation status of the IGHV gene is essential for treating patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Unlike the…”
Get full text

Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a “Spike-in” Clonal Sequence by Ho, Caleb, Syed, Mustafa, Yu, Wayne, Petrova-Drus, Kseniya, Yao, Jin Juan, Moung, Christine, Chang, Jason, Benhamida, Jamal, Vanderbilt, Chad, Roshal, Mikhail, Gao, Qi, Maciag, Lidia, Wang, Meiyi, Ma, Yuanyuan, Rustad, Even H, Huang, Ying, Hutt, Kasey, Miller, Jeffrey E, Landgren, Ola, Nafa, Khedoudja, Arcila, Maria E

“…Introduction: Next-generation sequencing (NGS)-based IGH clonal rearrangement assays can characterize and subsequently track disease-associated clonal…”
Get full text

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing by Ho, Caleb, Syed, Mustafa, Roshal, Mikhail, Petrova-Drus, Kseniya, Moung, Christine, Yao, Jinjuan, Quesada, Andres E., Benhamida, Jamal, Vanderbilt, Chad, Liu, Ying, Zhu, Menglei, Yu, Wayne, Maciag, Lidia, Wang, Meiyi, Ma, Yuanyuan, Gao, Qi, Rustad, Even H., Hultcrantz, Malin, Diamond, Benjamin T., Zheng-Lin, Binbin, Huang, Ying, Hutt, Kasey, Miller, Jeffrey E., Dogan, Ahmet, Nafa, Khedoudja, Landgren, Ola, Arcila, Maria E.

“…The 2016 International Myeloma Working Group consensus recommendations emphasize high-sensitivity methods for minimal residual disease (MRD) detection,…”
Get full text

Next-Generation Sequencing-Based Assay Shows High Clonal Characterization Success Rate for Plasma Cell Neoplasms, and Concordance with Flow Cytometry in Minimal Residual Disease Detection by Ho, Caleb, Syed, Mustafa, Roshal, Mikhail, Petrova-Drus, Kseniya, Moung, Christine, Yao, Jin Juan, Yu, Wayne, Maciag, Lidia, Benayed, Ryma, Hultcrantz, Malin, Dogan, Ahmet, Nafa, Khedoudja, Landgren, Ola, Arcila, Maria E

“…Introduction After therapy or stem cell transplantation, multiple myeloma patients achieving complete response (CR) or stringent complete response (sCR) can…”
Get full text